Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Longitudinal Bladder Cancer Study for Tumour Recurrence
A recruiting longitudinal study evaluating biomarker testing for monitoring tumour recurrence in bladder cancer.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy [NA]
Clinical trial update on using remote monitoring to improve patient-reported outcomes and reduce readmission after radical cystectomy for bl…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Sacituzumab Govitecan Plus EV in Metastatic UC [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating sacituzumab govitecan in combination with Enfortumab Vedotin for metastatic urothelial cancer; the …
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy [Phase 1]
A Phase 1 trial evaluating NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy for patients with advanced cancers; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of radiation therapy with a DLL3-targeting bispecific T-cell engager in DLL3-expres…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with BDB001 and immunogenic radiotherapy for advanced solid tumors is currentl…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors [Phase 2]
This Phase 2 clinical trial investigates several radiation dose levels for patients whose cancers progressed on immunotherapy/checkpoint inh…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy [NA]
A clinical trial update on using comprehensive geriatric assessment tests for bladder cancer patients undergoing radical cystectomy, current…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Gender Related Coping and Survivorship for Genitourinary Cancers
A Johns Hopkins University-sponsored clinical trial is currently recruiting to study gender-related coping and survivorship in bladder cance…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Patients: A Randomized Controlled Trial and Observational Study [NA]
This entry reports a randomized controlled trial and observational study aiming to improve patient comfort and reduce anxiety during flexibl…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Validity of Parametric MRI Using VIRADS [NA]
This clinical trial update evaluates the validity of parametric MRI using VIRADS for bladder cancer and notes that the study is currently re…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy [NA]
An ongoing clinical trial from Changhai Hospital is evaluating intracavitary cryoablation combined with immunotherapy for bladder-preserving…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor [NA]
Registry entry for a clinical trial evaluating whether video calls with family during operating room waiting influence stress, anxiety, and …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer
A clinical trial to assess safety, tolerance, and preliminary efficacy of gamma-delta T cell injections for advanced bladder cancer. It is c…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors [Phase 2]
Phase 2 clinical trial update for BL-B01D1 in patients with multiple solid tumors, including locally advanced or metastatic urinary system t…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer
This clinical trial update outlines an ongoing study assessing supportive care and educational needs to guide quality care improvements for …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Mobile Ostomates Resources for Patients and Caregivers [NA]
A completed clinical trial update regarding mobile ostomates resources for patients and caregivers, sponsored by Icahn School of Medicine at…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study [Phase 2]
This update describes an open-label, randomized Phase 2 trial evaluating toripalimab with or without sequential intravesical gemcitabine-mit…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer [Phase 2]
Clinical trial update for a Phase 2 neoadjuvant trial of dose-dense gemcitabine and cisplatin in muscle-invasive bladder cancer; the study s…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer
An enrolling-by-invitation clinical trial from Linköping University studying information needs and supportive rehabilitation over time for p…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating enfortumab vedotin in combination with stereotactic radiation for localized, cisplatin-ineligible muscle-inv…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer [NA]
A clinical trial update for JING SI HERBAL TEA investigating urinary tract symptoms in bladder cancer patients; enrollment is by invitation …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination—fluorouracil, leucovorin, gemcitabine, and cisplatin—for metastatic or unresectabl…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Genotype-Phenotype Urothelial Cancer Registry
A genotype-phenotype urothelial cancer registry sponsored by Memorial Sloan Kettering Cancer Center; the study is active but not recruiting.